Scopolamine reduces frontal cortex perfusion

W. G. Honer, I. Prohovnik, Gwenn Smith, L. R. Lucas

Research output: Contribution to journalArticle

Abstract

While the cognitive deficits of Alzheimer's disease are considered related to a cholinergic deficit, no attempt has yet been made to test the hypothesis that the characteristic regional cerebral blood flow (rCBF) pattern of Alzheimer's disease may also relate to such a deficit. We therefore measured rCBF using the [133Xe] inhalation technique in 15 young normal subjects before and after induction of reversible cholinergic blockade with scopolamine at doses of 6.1 and 7.3 μg/kg i.v. Significant cognitive impairment was observed at both doses, while rCBF changes occurred only at the higher dose. Global CBF was significantly reduced 25 min after scopolamine. The pattern of regional change in CBF was not similar to Alzheimer's disease. Rather than a focal parietotemporal deficit as seen in Alzheimer's disease, we observed a predominantly frontal reduction in flow of about 20%. These results suggest that the frontal but not the parietotemporal deficits seen in several dementing conditions may be related to cholinergic dysfunction.

Original languageEnglish (US)
Pages (from-to)635-641
Number of pages7
JournalJournal of Cerebral Blood Flow and Metabolism
Volume8
Issue number5
StatePublished - 1988
Externally publishedYes

Fingerprint

Cerebrovascular Circulation
Scopolamine Hydrobromide
Frontal Lobe
Regional Blood Flow
Alzheimer Disease
Perfusion
Cholinergic Agents
Inhalation

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Neuroscience(all)

Cite this

Honer, W. G., Prohovnik, I., Smith, G., & Lucas, L. R. (1988). Scopolamine reduces frontal cortex perfusion. Journal of Cerebral Blood Flow and Metabolism, 8(5), 635-641.

Scopolamine reduces frontal cortex perfusion. / Honer, W. G.; Prohovnik, I.; Smith, Gwenn; Lucas, L. R.

In: Journal of Cerebral Blood Flow and Metabolism, Vol. 8, No. 5, 1988, p. 635-641.

Research output: Contribution to journalArticle

Honer, WG, Prohovnik, I, Smith, G & Lucas, LR 1988, 'Scopolamine reduces frontal cortex perfusion', Journal of Cerebral Blood Flow and Metabolism, vol. 8, no. 5, pp. 635-641.
Honer, W. G. ; Prohovnik, I. ; Smith, Gwenn ; Lucas, L. R. / Scopolamine reduces frontal cortex perfusion. In: Journal of Cerebral Blood Flow and Metabolism. 1988 ; Vol. 8, No. 5. pp. 635-641.
@article{266e855dc8564ba1ac859c85d89c9cce,
title = "Scopolamine reduces frontal cortex perfusion",
abstract = "While the cognitive deficits of Alzheimer's disease are considered related to a cholinergic deficit, no attempt has yet been made to test the hypothesis that the characteristic regional cerebral blood flow (rCBF) pattern of Alzheimer's disease may also relate to such a deficit. We therefore measured rCBF using the [133Xe] inhalation technique in 15 young normal subjects before and after induction of reversible cholinergic blockade with scopolamine at doses of 6.1 and 7.3 μg/kg i.v. Significant cognitive impairment was observed at both doses, while rCBF changes occurred only at the higher dose. Global CBF was significantly reduced 25 min after scopolamine. The pattern of regional change in CBF was not similar to Alzheimer's disease. Rather than a focal parietotemporal deficit as seen in Alzheimer's disease, we observed a predominantly frontal reduction in flow of about 20{\%}. These results suggest that the frontal but not the parietotemporal deficits seen in several dementing conditions may be related to cholinergic dysfunction.",
author = "Honer, {W. G.} and I. Prohovnik and Gwenn Smith and Lucas, {L. R.}",
year = "1988",
language = "English (US)",
volume = "8",
pages = "635--641",
journal = "Journal of Cerebral Blood Flow and Metabolism",
issn = "0271-678X",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Scopolamine reduces frontal cortex perfusion

AU - Honer, W. G.

AU - Prohovnik, I.

AU - Smith, Gwenn

AU - Lucas, L. R.

PY - 1988

Y1 - 1988

N2 - While the cognitive deficits of Alzheimer's disease are considered related to a cholinergic deficit, no attempt has yet been made to test the hypothesis that the characteristic regional cerebral blood flow (rCBF) pattern of Alzheimer's disease may also relate to such a deficit. We therefore measured rCBF using the [133Xe] inhalation technique in 15 young normal subjects before and after induction of reversible cholinergic blockade with scopolamine at doses of 6.1 and 7.3 μg/kg i.v. Significant cognitive impairment was observed at both doses, while rCBF changes occurred only at the higher dose. Global CBF was significantly reduced 25 min after scopolamine. The pattern of regional change in CBF was not similar to Alzheimer's disease. Rather than a focal parietotemporal deficit as seen in Alzheimer's disease, we observed a predominantly frontal reduction in flow of about 20%. These results suggest that the frontal but not the parietotemporal deficits seen in several dementing conditions may be related to cholinergic dysfunction.

AB - While the cognitive deficits of Alzheimer's disease are considered related to a cholinergic deficit, no attempt has yet been made to test the hypothesis that the characteristic regional cerebral blood flow (rCBF) pattern of Alzheimer's disease may also relate to such a deficit. We therefore measured rCBF using the [133Xe] inhalation technique in 15 young normal subjects before and after induction of reversible cholinergic blockade with scopolamine at doses of 6.1 and 7.3 μg/kg i.v. Significant cognitive impairment was observed at both doses, while rCBF changes occurred only at the higher dose. Global CBF was significantly reduced 25 min after scopolamine. The pattern of regional change in CBF was not similar to Alzheimer's disease. Rather than a focal parietotemporal deficit as seen in Alzheimer's disease, we observed a predominantly frontal reduction in flow of about 20%. These results suggest that the frontal but not the parietotemporal deficits seen in several dementing conditions may be related to cholinergic dysfunction.

UR - http://www.scopus.com/inward/record.url?scp=0023749833&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023749833&partnerID=8YFLogxK

M3 - Article

C2 - 3417793

AN - SCOPUS:0023749833

VL - 8

SP - 635

EP - 641

JO - Journal of Cerebral Blood Flow and Metabolism

JF - Journal of Cerebral Blood Flow and Metabolism

SN - 0271-678X

IS - 5

ER -